Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
Authors
Keywords
-
Journal
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
Volume 18, Issue -, Pages 153303381982948
Publisher
SAGE Publications
Online
2019-02-14
DOI
10.1177/1533033819829485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?
- (2015) Eun Young Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer
- (2015) Lian Lian et al. Cancer Biomarkers
- Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
- (2015) David A. Quigley et al. Molecular Oncology
- Neoadjuvant or adjuvant therapy for gastric cancer
- (2015) Laurent Quéro World Journal of Gastrointestinal Oncology
- Identification of prognostic factors and surgical indications for metastatic gastric cancer
- (2014) Yasuhiko Mohri et al. BMC CANCER
- Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review
- (2014) Rebekka Schirren et al. Therapeutic Advances in Medical Oncology
- Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
- (2013) X. Wang et al. Clinical & Translational Oncology
- Chemotherapy for Advanced Gastric Cancer: Review and Update of Current Practices
- (2013) Sung Chul Park et al. Gut and Liver
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer
- (2013) Serta Kılınçalp et al. PLATELETS
- Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
- (2012) Katy Milne et al. Journal of Translational Medicine
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Platelets govern pre-metastatic tumor communication to bone
- (2012) B A Kerr et al. ONCOGENE
- Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
- (2011) M. Pera et al. ANNALS OF ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- 7th Edition of the AJCC Cancer Staging Manual: Stomach
- (2010) Kay Washington ANNALS OF SURGICAL ONCOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- The platelet contribution to cancer progression
- (2010) N. M. BAMBACE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started